Improvement of psoriasis and cutaneous side-effects during tyrosine kinase inhibitor therapy for renal metastatic adenocarcinoma. A role for epidermal growth factor receptor (EGFR) inhibitors in psoriasis? [4]

British Journal of Dermatology

Volumn 155, Issue 1, 2006, Pages 213-214

  Wierzbicka, E ^a   Tourani, J M ^a   Guillet, G ^a  

^a UNIVERSITÉ DE POITIERS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

4 (3 BROMOANILINO) 6,7 DIMETHOXYQUINAZOLINE; 4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZOLINE; BENZOYL PEROXIDE; BETAMETHASONE; CALCIPOTRIOL; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR; GEFITINIB; IMATINIB; LITHIUM GLUCONATE; PROTEIN TYROSINE KINASE INHIBITOR; RETINOIC ACID;

ACNE; ADULT; ANAMNESIS; CASE REPORT; DESQUAMATION; DISEASE EXACERBATION; DRUG EFFICACY; DRUG ERUPTION; DRUG TOLERABILITY; DRUG TREATMENT FAILURE; FOLLICULITIS; HUMAN; KIDNEY CARCINOMA; LETTER; LUNG METASTASIS; MALE; PRIORITY JOURNAL; PSORIASIS; RASH; SEBORRHEIC DERMATITIS; SKIN DEFECT; SKIN INFLAMMATION; SKIN IRRITATION; SKIN TOXICITY; TREATMENT OUTCOME; XEROSIS;

ADENOCARCINOMA; HUMANS; KIDNEY NEOPLASMS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROTEIN KINASE INHIBITORS; PROTEIN-TYROSINE KINASES; PSORIASIS; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 33745020186     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2006.07299.x     Document Type: Letter

References (6)

1. Spector NL Xia W Burris H III. et al. Study of the biological effects of lapatinib, a reversible inhibitor of ErbB1 and ErbB2 tyrosine kinases, on tumor growth and survival pathways in patients with advanced malignancies. J Clin Oncol 2005 23 : 2502 12.
2. Miyagawa S Fujimoto H Ko S et al. Improvement of psoriasis during imatinib therapy in a patient with a metastatic gastrointestinal stromal tumour. Br J Dermatol 2002 147 : 406 7.
3. Jost M Class R Kari C et al. A central role of Bcl-X(L) in the regulation of keratinocyte survival by autocrine EGFR ligands. J Invest Dermatol 1999 112 : 443 9.
4. Gottlieb AB Chang CK Posnett DN et al. Detection of transforming growth factor alpha in normal, malignant and hyperproliferative human keratinocytes. J Exp Med 1988 167 : 670 5.
5. Ben-Bassat H. Biological activity of tyrosine kinase inhibitors: novel agents for psoriasis therapy. Curr Opin Investig Drugs 2001 2 : 1539 45.
6. Lee MW Seo CW Kim SW et al. Cutaneous side effects in non-small cell lung cancer patients treated with Iressa (ZD1839), an inhibitor of epidermal growth factor. Acta Derm Venereol 2004 84 : 23 6.